# Aura Biosciences, Inc.: Form 10-K/A for the period ended Dec 31, 2023

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 10-K/A
- Filed: 2024-06-14
- Accepted by EDGAR: Jun 14, 2024, 16:37 ET
- Period: 2023-12-31
- Accession: 0001193125-24-161680
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000119312524161680/d650467d10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000119312524161680/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000119312524161680/d650467d10ka.htm

Filed Jun 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-161680. Last ingested by Listed: Nov 9, 2026, 17:30 ET. No prices; not investment advice.